Related Experiment Videos
Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia
H Khoury1, D Adkins, B Zehnbauer
1Washington University School of Medicine, Division of Bone Marrow Transplantation and Stem Cell Biology, St. Louis, MO 63110, USA.
Bone Marrow Transplantation
|July 25, 1998
Abstract:
Allogeneic transplant recipients are at high risk of developing secondary malignancies as a late complication of therapy. We report a case of essential thrombocythemia occurring 8 years following bone marrow transplantation (BMT) for chronic myelogenous leukemia.